Tony Huge’s hematocrit came back at 59%. That number is the headline, but the video is really about the trade nobody explains when they tell a man on testosterone to go donate blood. The draw fixes thickness this month and quietly drains iron all year, and Tony argues you cannot manage one without watching the other.
Video: My Hematocrit Hit 59% on TRT and Here’s What Nobody Tells You. Published September 23, 2026. Watch on YouTube.
What the video covers
- 00:00 The number: Hematocrit 59%, hemoglobin 18.6, and the question of whether anyone on TRT has actually been told to look at blood thickness.
- 00:28 Why testosterone thickens blood: Bone marrow, red cell production, and why this is the body doing exactly what it was told.
- 00:48 The 19-trial number: Men on testosterone were 3.7 times as likely to cross 50% hematocrit, the most common adverse finding across those trials.
- 01:09 Does thick blood hurt you? The polycythemia vera trial: 2.7% versus 9.8% for cardiovascular death or major clot.
- 01:39 Why that trial does not transfer: Polycythemia vera is a bone marrow cancer. A man on testosterone has different biology, and nobody funds the phlebotomy trial that would settle it.
- 02:18 The hidden cost: Each whole blood draw pulls 200 to 250 mg of iron, and recovery takes months.
- 02:28 The donor study: Among frequent male donors, 47% had iron-starved red cell production and 18% had no iron stores at all.
- 02:52 Why iron matters beyond anemia: Neurotransmitters, brain function, and what Tony learned from Conor Murphy’s iron story.
- 03:29 Two numbers: Hematocrit tells you the risk. Ferritin tells you what the fix is costing.
- 04:08 Hydration: Dehydration makes the problem worse, and a well-hydrated blood draw can hide a thick-blood baseline.
The body is doing what it was told
Tony opens with a framing most TRT patients never hear. Testosterone signals bone marrow to build more red blood cells. More cells in the same volume of fluid means thicker blood. That is not a malfunction. It is the expected response to an androgen signal, and it is why he treats elevated hematocrit as a management problem rather than an emergency.
The scale of that response is where the research comes in. Tony cites a pooled analysis of 19 randomized trials, 651 men on testosterone against 433 on placebo, in which the men on testosterone were 3.7 times as likely to push hematocrit above 50%. Out of everything measured in those trials, he notes, that was the most common problem. His own 59% with a hemoglobin of 18.6 sits well beyond that threshold.
The obvious next question is whether thick blood actually causes harm or just looks bad on paper. Tony answers with a trial in 365 adults where half were treated aggressively to hold hematocrit below 45% and half were allowed to run between 45 and 50. Over roughly 31 months, cardiovascular death or a major clot hit 2.7% in the thin group and 9.8% in the thick group. That is close to a fourfold difference.
Why he refuses to apply that trial to himself
This is the part of the video that separates it from most TRT content. Every one of those 365 patients had polycythemia vera, a bone marrow cancer that drives red cell production on its own. A man whose hematocrit is high because of testosterone does not share that biology, so Tony is explicit that the trial does not transfer to him automatically.
His explanation for why no better trial exists is an incentive argument rather than a scientific one. A phlebotomy is a needle and a bag. There is no molecule to patent, nothing to sell every month, and companies fund trials to protect a commercial position. There is no position to protect in taking blood out of someone’s arm, so the question of what target hematocrit a TRT patient should hold stays unanswered.
“Companies fund trials to protect a position, and there’s no position to protect in taking blood out of your arm.”
Tony Huge, 01:57
The fix has a price, and the price is iron
The mechanism behind the second half of the video is simple: red blood cells are where most of the body’s iron lives. Every whole blood draw removes 200 to 250 mg of it, and Tony stresses that rebuilding those stores takes months, not weeks. Do that repeatedly and you are running a slow iron deficit while congratulating yourself on a lower hematocrit.
He backs that with a study of 2,425 blood donors. Among the men who donated often, 47% showed iron-starved red cell production and 18% had no measurable iron stores at all. Tony’s point is that these were healthy volunteers doing a good deed too frequently, and they ended up with lab pictures a clinician would treat. The TRT patient doing therapeutic phlebotomy every few months is walking the same road with a different reason.
Why does that matter beyond anemia? Tony points to the role of iron in brain neurotransmitters and cognitive function, and mentions an interview with Conor Murphy, who described resolving a long list of health problems once his iron deficiency was corrected. Low iron, in Tony’s framing, is a mental problem as much as a physical one.
Two numbers, watched together
The core argument lands here. Hematocrit tells you the risk. Ferritin tells you what the fix is costing you. The answer sits between two failure modes, thick blood on one side and depleted iron on the other, and the only instrument for steering between them is blood work that includes both. Most standard panels include hematocrit. Most do not include ferritin or iron unless someone asks.
Tony adds a measurement caveat that catches a lot of people. Dehydration concentrates the blood, so a dehydrated draw reads thicker than baseline, and a well-hydrated draw can read thinner than what you carry around most of the day. He describes a coach reminding him to drink far more water in hot weather because his blood already ran thick, and he suggests remembering how much water you drank before any panel so you can interpret the number honestly.
Cheat Sheet Pivot
These are the practical points Tony reported in the video, framed as what he does and what the cited studies measured, not as instructions for anyone else.
- Tony asks for hematocrit and ferritin together on every panel, and treats a hematocrit above 50 that nobody has mentioned as something to raise with a doctor.
- He uses therapeutic phlebotomy periodically to bring hematocrit down, and says he feels lighter afterward.
- To offset the iron cost, he eats a lot of red meat and keeps iron supplementation on hand, checking ferritin before any further blood removal.
- The donor study he cites found iron depletion in roughly half of frequent male donors, which is why he treats each draw as a withdrawal from an iron account rather than a free reset.
- Hydration status changes the reading, so he pays attention to water intake before blood work and in hot weather generally.
The broader compound and marker references Tony keeps returning to are collected in the Miracle Molecules Cheat Sheet. For the mechanism of testosterone-driven red cell production in more depth, read Hematocrit on Testosterone: Erythrocytosis Explained, and for how Tony has approached blood removal in the past, see Hematocrit on TRT: The Blood Donation Protocol.
Where the evidence stops
Tony is unusually direct about the limits here. The only outcome trial he cites for hematocrit targets was run in polycythemia vera patients, and he says outright that it does not apply to testosterone-driven erythrocytosis automatically. No trial has established what hematocrit a TRT patient should hold or whether phlebotomy improves hard outcomes in that population.
The iron data comes from blood donors, not TRT patients on therapeutic phlebotomy, and Conor Murphy’s improvement is one person’s account. The video does not name a ferritin target or a phlebotomy frequency, and it does not claim that correcting iron reverses any specific symptom. What it establishes is a monitoring principle: two markers, tracked together, interpreted with hydration in mind.
Keep going
If you want to read your own panel the way Tony reads his, Reading Your Own Bloodwork: The Markers That Actually Change Decisions is the next stop. New videos get a companion write-up like this one, and the fastest way to get them is the tonyhuge.is email list. The rest of the TRT and blood work archive is on tonyhuge.is.